Evaluation of a Clinical Program Specialized in the Diagnosis, Follow-up and Treatment of Young Adults With a Autism Spectrum Disorder: "TAVA" (Spanish Acronym for "Support to Subjects With Autism in Their Transition to Adulthood")
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 102
- Locations
- 1
- Primary Endpoint
- Change in Quality of life.
Study Overview
Brief Summary
Clinical trial without drug, randomized: Comparison of a specific and integrative clinical protocol for young adults with autism to usual treatment. It will include both low and high-functioning participants.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Outcomes Assessor)
Masking Description
A researcher will be masked for group aleatorization (active, group) in order to unbiasedly evaluate outcomes which require subjective assesment of functionality.
Eligibility Criteria
- Ages
- 18 Years to 21 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •ASD diagnosis
- •Previous follow-up by child and adolescent psychiatry department at Corporació Sanitària Parc Taulí (CSPT)
Exclusion Criteria
- •Living in a disabled residential setting
Arms & Interventions
TAVA-ACTIVE
Integrative interventional programme. It involves high-frequency multidisciplinary intervention: nursing, psychology, psychiatry and social services. A psychotherapeutic group would be offered to those patients with an intelligence quotient>70, verbal communication and no behavioural alterations.
Intervention: Integrative interventional programme (Other)
CONTROL
As usual
Intervention: As usual (Other)
Outcomes
Primary Outcomes
Change in Quality of life.
Time Frame: Baseline, 24 months
The World Health Organization Quality of Life (WHOQOL). Self-administered scale, quantitative. Spanish version.
Secondary Outcomes
- Change in: ASD symptoms evaluated by parents/caregiver.(Baseline, 24 months)
- Change in: ASD symptoms.(Baseline, 24 months)
- Change in: Depressive symptoms(Baseline, 24 months)
- Change in: Caregiver's burden associated with the disorder.(Baseline, 24 months)
- Change in: Asperger Symptoms.(Baseline, 24 months)
- Change in: Evaluation of support needs.(Baseline, 24 months)
- Change in: Evaluation of the level of autonomy, self-regulation, self-empowerment, self-knowledge.(Baseline, 24 months)
- Change in: Anxiety Symptoms.(Baseline, 24 months)
- Change in: Social phobia symptoms.(Baseline, 24 months)
- Change in: Obsessive-compulsive symptoms.(Baseline, 24 months)
Investigators
Esther Via
Principal Investigator
Corporacion Parc Tauli